Premark Pharma Company
Premark Pharma GmbH is a company focused on the development and commercialisation of topical treatments for inflammatory diseases of the skin, eye, mucosae and mucocutaneous surfaces. The company's primary business objective is to achieve a marketing approval in EU and US for the first prescription treatment for blepharitis.